Pinnacle Bancorp’s Haemonetics HAE Stock Holding History

Pinnacle Bancorp’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-183	Closed	-$15.1K	–	780
2023 Q1	$15.1K	Buy	+183	New	+$14.8K	0.01%	540

Other funds holding HAE

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pinnacle Bancorp's HAE Position: Q2 2023 in Review

Pinnacle Bancorp sold out of Haemonetics (HAE) in Q2 2023, closing a stake of 183 shares — an estimated $15.1K sold.

Pinnacle Bancorp first reported a position in HAE in Q1 2023 and held it in 1 quarter. The position peaked at $15.1K in Q1 2023. 294 funds tracked by Wall St. Rank hold HAE as of Q2 2023.

Pinnacle Bancorp reported no remaining Haemonetics position as of Q2 2023 after selling out during the quarter.
Pinnacle Bancorp sold 183 Haemonetics shares in Q2 2023, an estimated $15.1K.
Pinnacle Bancorp first reported a position in Haemonetics in Q1 2023 and held it in 1 quarter.
Pinnacle Bancorp's Haemonetics position peaked at $15.1K in Q1 2023.
294 funds tracked by Wall St. Rank held Haemonetics as of Q2 2023.

Based on Pinnacle Bancorp's 13F filing for Q2 2023, filed 14 Jul 2023.